AMERICA'S STEM CELL BANK Trademark
Trademark Overview
On Tuesday, August 26, 2003, a trademark application was filed for AMERICA'S STEM CELL BANK with the United States Patent and Trademark Office. The USPTO has given the AMERICA'S STEM CELL BANK trademark a serial number of 78292084. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, June 4, 2005. This trademark is owned by Celgene Corporation. The AMERICA'S STEM CELL BANK trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
pharmaceutical preparations for use with biological tissue intended for subsequent implantation; pharmaceutical preparations for use in the collection and preservation of human blood, umbilical cord blood, stem cells, umbilical cords and placentas; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of oncology, inflammation, dermatology and ophthalmology diseases
research, development and testing services for others in the fields of biotechnology, chemistry and pharmaceuticals
General Information
| Serial Number | 78292084 |
| Word Mark | AMERICA'S STEM CELL BANK |
| Filing Date | Tuesday, August 26, 2003 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Saturday, June 4, 2005 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | pharmaceutical preparations for use with biological tissue intended for subsequent implantation; pharmaceutical preparations for use in the collection and preservation of human blood, umbilical cord blood, stem cells, umbilical cords and placentas; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of oncology, inflammation, dermatology and ophthalmology diseases |
| Goods and Services | research, development and testing services for others in the fields of biotechnology, chemistry and pharmaceuticals |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 3, 2003 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 3, 2003 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Celgene Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Warren, NJ 07059 |
Trademark Events
| Event Date | Event Description |
| Monday, June 6, 2005 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Saturday, June 4, 2005 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Saturday, June 4, 2005 | ASSIGNED TO EXAMINER |
| Thursday, February 17, 2005 | ASSIGNED TO EXAMINER |
| Wednesday, October 13, 2004 | NON-FINAL ACTION E-MAILED |
| Wednesday, October 13, 2004 | NON-FINAL ACTION WRITTEN |
| Monday, October 4, 2004 | AMENDMENT FROM APPLICANT ENTERED |
| Monday, September 20, 2004 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, September 20, 2004 | PAPER RECEIVED |
| Wednesday, March 24, 2004 | NON-FINAL ACTION E-MAILED |
| Sunday, March 14, 2004 | ASSIGNED TO EXAMINER |
